|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,550.20 INR | +1.47% |
|
+2.60% | +3.21% |
| Market Cap | 432B 4.49B 3.94B 3.66B 3.36B 6.32B 6.42B 43.51B 17B 212B 16.84B 16.48B 734B | P/E 2027 * |
37x | P/E 2028 * | 32.9x |
|---|---|---|---|---|---|
| Enterprise Value | 432B 4.49B 3.94B 3.66B 3.36B 6.32B 6.42B 43.51B 17B 212B 16.84B 16.48B 734B | EV / Sales 2027 * |
10.3x | EV / Sales 2028 * | 9.29x |
| Free-Float |
24.37% | Yield 2027 * |
1.17% | Yield 2028 * | 1.17% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +1.47% | ||
| 1 week | +2.60% | ||
| Current month | +4.05% | ||
| 1 month | +8.30% | ||
| 3 months | +4.30% | ||
| 6 months | +9.02% | ||
| Current year | +3.21% |
| 1 week | 2,455 |  | 2,599.8 |
| 1 month | 2,336.1 | | 2,599.8 |
| Current year | 2,088 | | 2,715.15 |
| 1 year | 2,088 | | 3,202.8 |
| 3 years | 1,386.55 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 07/04/2017 |
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.47% | +2.60% | -17.44% | +82.22% | 4.42B | |
| +0.50% | +4.74% | +48.65% | +164.02% | 1,067B | |
| +1.41% | +7.03% | +60.21% | +53.32% | 635B | |
| +0.59% | +3.17% | +38.66% | +75.61% | 458B | |
| +1.87% | +9.10% | +38.87% | +32.83% | 347B | |
| +1.72% | +4.94% | +38.40% | +42.35% | 295B | |
| +2.07% | +4.80% | +20.24% | +21.25% | 262B | |
| +1.43% | -1.01% | -28.03% | -38.99% | 216B | |
| +1.27% | +4.52% | +26.34% | +61.25% | 203B | |
| +2.38% | -1.37% | +16.24% | +71.73% | 161B | |
| Average | +1.54% | +1.43% | +24.21% | +56.56% | 364.79B | |
| Weighted average by Cap. | +1.27% | +1.95% | +38.32% | +79.17% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.99B 436M 383M 356M 327M 614M 624M 4.23B 1.65B 20.64B 1.64B 1.6B 71.37B | 46.49B 483M 424M 394M 362M 680M 690M 4.68B 1.83B 22.86B 1.81B 1.77B 79.02B |
| Net income | 11.42B 119M 104M 96.84M 88.86M 167M 170M 1.15B 449M 5.61B 445M 435M 19.41B | 12.54B 130M 114M 106M 97.62M 183M 186M 1.26B 494M 6.17B 489M 478M 21.32B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | ₹2,550.20 | +1.47% | 2,697 |
| 24/07/26 | ₹2,513.25 | +0.76% | 3,064 |
| 23/07/26 | ₹2,494.20 | -2.23% | 3,198 |
| 22/07/26 | ₹2,551.10 | +1.83% | 4,731 |
| 21/07/26 | ₹2,505.30 | +0.79% | 3,412 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
